← Leaderboards
Shawn Brady Bender
Harry S. Truman Memorial Va Hospital
$2,980,327
Attributed
$3,437,430
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $685.7K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,437,430 · 2
VA$0 · 1
By mechanism
R01$3,437,430 · 2
IK2$0 · 1
Top collaborators
- Luis A Martinez-Lemus1 shared
- Jaume Padilla1 shared
Most similar at Harry S. Truman Memorial Va Hospital
Same institution · by research overlap
- Camila Margarita Manrique Acevedo$5,456,962
- Shiyou Chen$16,685,151
- William P Fay$8,557,177
- Jaume Padilla$7,120,291
Others in their field
Top investigators on “Receptor Activation”
- Bert W O'Malley · Baylor College Of Medicine$94,756,238
- Asrar B. Malik · University Of Illinois At Chicago$57,541,158
- Mark M Davis · Stanford University$49,302,870
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$46,277,815
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,169,179
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
Research focus
Receptor ActivationFunctional DisorderInnovationHypertensionMineralocorticoid ReceptorIncidenceMolecularRenin-Angiotensin-Aldosterone SystemBlood VesselsBlood PressureIn VivoCell Culture TechniquesKnockout MiceCardiovascular SystemIn VitroDefectLaboratoriesHomeostasisBlood FlowAldosteroneImpairmentFeedingEventCoronary
Grant awards (11)
Tissue transglutaminase as a therapeutic target for arterial stiffening and hypertension in obesity$685,654
R01 · FY2025 · HL
Mineralocorticoid receptor-dependent coronary vascular dysfunction in obesity$549,371
R01 · FY2022 · HL · contact PI
Mineralocorticoid receptor-dependent coronary vascular dysfunction in obesity$549,371
R01 · FY2021 · HL · contact PI
Mineralocorticoid receptor-dependent coronary vascular dysfunction in obesity$549,371
R01 · FY2020 · HL · contact PI
Mineralocorticoid receptor-dependent coronary vascular dysfunction in obesity$549,371
R01 · FY2019 · HL · contact PI
Mineralocorticoid receptor-dependent coronary vascular dysfunction in obesity$554,292
R01 · FY2018 · HL · contact PI
Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance$0
IK2 · FY2017 · VA · contact PI
Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance$0
IK2 · FY2016 · VA · contact PI
Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance$0
IK2 · FY2015 · VA · contact PI
Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance$0
IK2 · FY2014 · VA · contact PI
Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance$0
IK2 · FY2013 · VA · contact PI